Unison Advisors’s iRadimed IRMD Stock Holding History

Unison Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-29,250	Closed	-$413K	–	170
2018 Q1	$413K	Hold	29,250	–	–	0.31%	80
2017 Q4	$443K	Buy	+29,250	New	+$372K	0.32%	77

Other funds holding IRMD

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Unison Advisors's IRMD Position: Q2 2018 in Review

Unison Advisors sold out of iRadimed (IRMD) in Q2 2018, closing a stake of 29,250 shares — an estimated $413K sold.

Unison Advisors first reported a position in IRMD in Q4 2017 and held it in 2 quarters. The position peaked at $443K in Q4 2017. 51 funds tracked by Wall St. Rank hold IRMD as of Q2 2018.

Unison Advisors reported no remaining iRadimed position as of Q2 2018 after selling out during the quarter.
Unison Advisors sold 29,250 iRadimed shares in Q2 2018, an estimated $413K.
Unison Advisors first reported a position in iRadimed in Q4 2017 and held it in 2 quarters.
Unison Advisors's iRadimed position peaked at $443K in Q4 2017.
51 funds tracked by Wall St. Rank held iRadimed as of Q2 2018.

Based on Unison Advisors's 13F filing for Q2 2018, filed 19 Jul 2018.